Risks for Anaphylaxis Compared Among IV Iron Products
TUESDAY, March 29, 2022 (HealthDay News) — The rates of anaphylaxis are low for commonly used intravenous (IV) iron products, but the risk for anaphylaxis is increased for iron dextran and ferumoxytol compared with iron sucrose, according to a study …
Learn MoreNo Adverse Outcomes Seen With SARS-CoV-2 Vaccination in Pregnancy
TUESDAY, March 29, 2022 (HealthDay News) — Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy is not associated with adverse pregnancy outcomes, according to a study published online March 24 in the Jour…
Learn MoreFor Men Aged 60 to 64, CVD Deaths Up With Warmer Summer Nights
TUESDAY, March 29, 2022 (HealthDay News) — Warmer summer nights are associated with an increased risk for cardiovascular disease (CVD) death among men aged 60 to 64 years, according to a study published online March 28 in BMJ Open.Haris Majeed and Jo…
Learn MoreMemory Deficits Seen in Individuals With ‘Long COVID’
TUESDAY, March 29, 2022 (HealthDay News) — Individuals with “long COVID” have memory deficits, with increased deficits seen in association with the severity of ongoing self-reported symptoms, according to research published online March 17 in Frontie…
Learn MorePrenatal Occupational Disinfectant Use Tied to Child Allergies
TUESDAY, March 29, 2022 (HealthDay News) — Occupational disinfectant use by pregnant women is associated with increased risks for asthma and eczema in their offspring, according to a study published online March 28 in Occupational & Environmental Med…
Learn MoreImmune Response to SARS-CoV-2 Infection Persists in Children
TUESDAY, March 29, 2022 (HealthDay News) — Most children and adolescents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies following natural infection retain these antibodies for at least six months, according to research p…
Learn MoreRisk for Ischemic Stroke Up With Antidopaminergic Antiemetic Use
TUESDAY, March 29, 2022 (HealthDay News) — The risk for ischemic stroke is increased in association with the use of antidopaminergic antiemetics (ADAs), according to a study published online March 23 in The BMJ.Anne Bénard-Laribière, from the Univers…
Learn MoreAAD: Baricitinib Tops Placebo for Hair Regrowth in Alopecia Areata
MONDAY, March 28, 2022 (HealthDay News) — For adults with severe alopecia areata, oral baricitinib is superior to placebo with respect to hair regrowth at 36 weeks, according to a study published online March 26 in the New England Journal of Medicine…
Learn MoreStakes Are High Ahead of FDA Panel Vote on ALS Drug
MONDAY, March 28, 2022 (HealthDay News) — Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for amyotrophic lateral sclerosis (ALS), with a decision expected this week.The push to approve th…
Learn MoreBiden Administration to Offer Second COVID-19 Boosters to Those 50+
MONDAY, March 28, 2021 (HealthDay News) — Despite not knowing how long another jab might provide protection, the Biden administration plans to offer a second COVID-19 booster shot to Americans 50 and older.Optional second boosters of the Pfizer or Mo…
Learn More